nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Meta-analysis of the Risk of Adverse Cardiovascular Events in Patients with Cancer Treated with Inhibitors of the PI3K/AKT/mTOR Signaling Pathway
|
Liang, Xiao |
|
|
25 |
2 |
p. 269-281 |
artikel |
2 |
Associations Between Lead and Cadmium Exposure and Subclinical Cardiovascular Disease in U.S. Adults
|
Liu, Lin |
|
|
25 |
2 |
p. 282-293 |
artikel |
3 |
Astemizole Exacerbates 5-Fluorouracil-Triggered Cardiotoxicity by Enhancing Ptgs2
|
Xie, Mengshi |
|
|
25 |
2 |
p. 205-215 |
artikel |
4 |
Cardiotoxicity Associated With a Low Doses of 5-FU Promotes Morphoquantitative Changes in the Intrinsic Cardiac Nervous System
|
da Costa Salomão, Karile Cristina |
|
|
25 |
2 |
p. 193-204 |
artikel |
5 |
Dihydromyricetin Protects Against Hypoxia/Reoxygenation Injury in Cardiomyocytes by Activating miR-34a-Mediated Notch1 Pathway
|
Li, Yanyang |
|
|
25 |
2 |
p. 294-305 |
artikel |
6 |
Doxorubicin or Epirubicin Versus Liposomal Doxorubicin Therapy—Differences in Cardiotoxicity
|
Buchalska, Barbara |
|
|
25 |
2 |
p. 248-268 |
artikel |
7 |
Small Molecules Targeting Mitochondria: A Mechanistic Approach to Combating Doxorubicin-Induced Cardiotoxicity
|
Pal, Chinmay |
|
|
25 |
2 |
p. 216-247 |
artikel |
8 |
The Protective Effects of Carvacrol Against Doxorubicin-Induced Cardiotoxicity In Vitro and In Vivo
|
Retnosari, Rini |
|
|
25 |
2 |
p. 167-181 |
artikel |
9 |
Thiolutin Alleviates Cardiotoxic Effects of Doxorubicin by Suppressing NLRP3 Inflammasome in the Mouse Model
|
Cai, Wenyuan |
|
|
25 |
2 |
p. 182-192 |
artikel |
10 |
Unraveling Cardiovascular Risks and Benefits of COVID-19 Vaccines: A Systematic Review
|
Satyam, Shakta Mani |
|
|
25 |
2 |
p. 306-323 |
artikel |